The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of outcomes for AJCC 8th Anatomic and Prognostic staging in contemporary triple negative breast cancer (TNBC) multisite registry.
 
Rajvi H. Shah
No Relationships to Disclose
 
Yen Y. Wang
No Relationships to Disclose
 
Karissa Finke
No Relationships to Disclose
 
Rachel Yoder
No Relationships to Disclose
 
Anne O'Dea
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Novartis; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Lauren Elizabeth Nye
No Relationships to Disclose
 
Sheshadri Madhusudhana
Employment - HCA Healthcare (I)
Stock and Other Ownership Interests - HCA Healthcare (I)
 
Marc Steven Hoffmann
Honoraria - Janssen Oncology
Speakers' Bureau - Janssen Oncology
 
Manana Elia
No Relationships to Disclose
 
Gregory James Crane
No Relationships to Disclose
 
Jennifer R. Klemp
Leadership - Cancer Survivorship Training
Stock and Other Ownership Interests - Cancer Survivorship Training
Honoraria - Myriad Genetics; Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - I am the founder and CEO of Cancer Survivorship Training, Inc., an online learing company for healthcare providers. The company is the 23rd start-up at the Univ of Kansas and have a license agreement with KU for utilization of my IP.
 
Qamar J. Khan
Consulting or Advisory Role - Novartis; pfizer; Roche/Genentech
Research Funding - Novartis
 
Bruce F. Kimler
No Relationships to Disclose
 
Priyanka Sharma
Consulting or Advisory Role - Abbvie; Almac Diagnostics; AstraZeneca; TapImmune Inc.
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Cosmo Biosciences (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Abbvie; Almac Diagnostics; AstraZeneca; Celgene